436 related articles for article (PubMed ID: 29184017)
1. Vaccination with Recombinant
Specht CA; Lee CK; Huang H; Hester MM; Liu J; Luckie BA; Torres Santana MA; Mirza Z; Khoshkenar P; Abraham A; Shen ZT; Lodge JK; Akalin A; Homan J; Ostroff GR; Levitz SM
mBio; 2017 Nov; 8(6):. PubMed ID: 29184017
[TBL] [Abstract][Full Text] [Related]
2. Protection against Experimental Cryptococcosis following Vaccination with Glucan Particles Containing Cryptococcus Alkaline Extracts.
Specht CA; Lee CK; Huang H; Tipper DJ; Shen ZT; Lodge JK; Leszyk J; Ostroff GR; Levitz SM
mBio; 2015 Dec; 6(6):e01905-15. PubMed ID: 26695631
[TBL] [Abstract][Full Text] [Related]
3. Protection of Mice against Experimental Cryptococcosis by Synthesized Peptides Delivered in Glucan Particles.
Specht CA; Homan EJ; Lee CK; Mou Z; Gomez CL; Hester MM; Abraham A; Rus F; Ostroff GR; Levitz SM
mBio; 2021 Feb; 13(1):e0336721. PubMed ID: 35089095
[TBL] [Abstract][Full Text] [Related]
4. Protection of mice against experimental cryptococcosis using glucan particle-based vaccines containing novel recombinant antigens.
Hester MM; Lee CK; Abraham A; Khoshkenar P; Ostroff GR; Levitz SM; Specht CA
Vaccine; 2020 Jan; 38(3):620-626. PubMed ID: 31699504
[TBL] [Abstract][Full Text] [Related]
5. A Heat-Killed
Wang Y; Wang K; Masso-Silva JA; Rivera A; Xue C
mBio; 2019 Nov; 10(6):. PubMed ID: 31772051
[No Abstract] [Full Text] [Related]
6. A Call to Arms: Quest for a Cryptococcal Vaccine.
Caballero Van Dyke MC; Wormley FL
Trends Microbiol; 2018 May; 26(5):436-446. PubMed ID: 29103990
[TBL] [Abstract][Full Text] [Related]
7. Development of protective inflammation and cell-mediated immunity against Cryptococcus neoformans after exposure to hyphal mutants.
Zhai B; Wozniak KL; Masso-Silva J; Upadhyay S; Hole C; Rivera A; Wormley FL; Lin X
mBio; 2015 Oct; 6(5):e01433-15. PubMed ID: 26443458
[TBL] [Abstract][Full Text] [Related]
8. Induction of Protective Immunity to Cryptococcal Infection in Mice by a Heat-Killed, Chitosan-Deficient Strain of Cryptococcus neoformans.
Upadhya R; Lam WC; Maybruck B; Specht CA; Levitz SM; Lodge JK
mBio; 2016 May; 7(3):. PubMed ID: 27165801
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of Cryptococcus neoformans protein fractions that induce protective immune responses.
Chaturvedi AK; Weintraub ST; Lopez-Ribot JL; Wormley FL
Proteomics; 2013 Dec; 13(23-24):3429-41. PubMed ID: 24170628
[TBL] [Abstract][Full Text] [Related]
10. Protective efficacy of antigenic fractions in mouse models of cryptococcosis.
Mansour MK; Yauch LE; Rottman JB; Levitz SM
Infect Immun; 2004 Mar; 72(3):1746-54. PubMed ID: 14977983
[TBL] [Abstract][Full Text] [Related]
11. Methodology for Anti-Cryptococcal Vaccine Development.
Chaturvedi AK; Wormley FL
Methods Mol Biol; 2017; 1625():129-140. PubMed ID: 28584988
[TBL] [Abstract][Full Text] [Related]
12.
Colombo AC; Rella A; Normile T; Joffe LS; Tavares PM; de S Araújo GR; Frases S; Orner EP; Farnoud AM; Fries BC; Sheridan B; Nimrichter L; Rodrigues ML; Del Poeta M
mBio; 2019 Apr; 10(2):. PubMed ID: 30940711
[No Abstract] [Full Text] [Related]
13. Purification and characterization of a second immunoreactive mannoprotein from Cryptococcus neoformans that stimulates T-Cell responses.
Huang C; Nong SH; Mansour MK; Specht CA; Levitz SM
Infect Immun; 2002 Oct; 70(10):5485-93. PubMed ID: 12228274
[TBL] [Abstract][Full Text] [Related]
14. Chitosan-Deficient Cryptococcus as Whole-Cell Vaccines.
Specht CA; Lam WC; Hester MM; Lourenco D; Levitz SM; Lodge JK; Upadhya R
Methods Mol Biol; 2024; 2775():393-410. PubMed ID: 38758333
[TBL] [Abstract][Full Text] [Related]
15. Epitope-Based Immunoinformatic Approach on Heat Shock 70 kDa Protein Complex of
Elhassan RM; Alsony NM; Othman KM; Izz-Aldin DT; Alhaj TA; Ali AA; Abashir LA; Ahmed OH; Hassan MA
J Immunol Res; 2021; 2021():9921620. PubMed ID: 34471644
[TBL] [Abstract][Full Text] [Related]
16. Immune evasion by
Hester MM; Carlson D; Lodge JK; Levitz SM; Specht CA
Front Immunol; 2024; 15():1356651. PubMed ID: 38469300
[No Abstract] [Full Text] [Related]
17. Dendritic cell-based immunization ameliorates pulmonary infection with highly virulent Cryptococcus gattii.
Ueno K; Kinjo Y; Okubo Y; Aki K; Urai M; Kaneko Y; Shimizu K; Wang DN; Okawara A; Nara T; Ohkouchi K; Mizuguchi Y; Kawamoto S; Kamei K; Ohno H; Niki Y; Shibuya K; Miyazaki Y
Infect Immun; 2015 Apr; 83(4):1577-86. PubMed ID: 25644007
[TBL] [Abstract][Full Text] [Related]
18. Feasibility and prospects for a vaccine to prevent cryptococcosis.
Casadevall A; Pirofski LA
Med Mycol; 2005 Dec; 43(8):667-80. PubMed ID: 16422296
[TBL] [Abstract][Full Text] [Related]
19. Cross-reactivity between vaccine antigens from the chitin deacetylase protein family improves survival in a mouse model of cryptococcosis.
Hester MM; Oliveira LVN; Wang R; Mou Z; Lourenco D; Ostroff GR; Specht CA; Levitz SM
Front Immunol; 2022; 13():1015586. PubMed ID: 36248898
[TBL] [Abstract][Full Text] [Related]
20. Vaccine-mediated immune responses to experimental pulmonary Cryptococcus gattii infection in mice.
Chaturvedi AK; Hameed RS; Wozniak KL; Hole CR; Leopold Wager CM; Weintraub ST; Lopez-Ribot JL; Wormley FL
PLoS One; 2014; 9(8):e104316. PubMed ID: 25119981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
